Table 3

Sample characteristics from Study 2

VariablesControl group (=29)Treatment group (=27)Statistical comparison
Demographic information
Age, M (SD)59.6 (11.2)57.1 (10.2) t(54)=0.86 (95% CI −3.28–8.23), p=0.393
Male, No. (%)22 (75.9)21 (77.8)χ² (1, n=56)=0.28, p=0.865
Ethnicity, No. (%)
 White16 (55.2)18 (66.7)χ² (1, n=56)=8.31, p=0.140
 Asian1 (3.4)
 Black2 (11.8)
 Mixed1 (3.4)
 Other2 (11.8)
 Missing11 (37.9)5 (18.5)
Clinical information
 Current smoker, No. (%)10 (34.5)9 (33.3)χ² (1, n=56)=8.31, p=0.140
 Ex-smoker, No. (%)6 (20.7)7 (25.9)χ² (1, n=56)=2.15, p=0.643
 Type II diabetes mellitus, No. (%)5 (17.2)4 (14.8)χ² (1, n=56)=0.61, p=0.805
 Hypertension, No. (%)15 (51.7)14 (51.9)χ² (1, n=56)=0.00, p=0.992
 Hypercholesterolaemia, No. (%)14 (48.3)9 (33.3)χ² (1, n=56)=1.29, p=0.256
 Angina, No. (%)5 (17.2)3 (11.1)χ² (1, n=56)=0.43, p=0.512
 Previous AMI, No. (%)4 (13.8)3 (11.1)χ² (1, n=56)=0.92, p=0.762
 Previous PCI, No. (%)5 (17.2)4 (14.8)χ² (1, n=56)=0.61, p=0.805
Hospitalisation information
 Transferred from another hospital, No. (%)14 (48.3)7 (25.9)χ² (1, n=56)=2.98, p=0.084
 Days in hospital, Mdn (IQR)3.0 (2.0)3.0 (5.0)(U=359.5, p=0.591)
 Type of ACS, No. (%)
 UA2 (6.9)2 (7.4)χ² (1, n=56)=2.70, p=0.259
 NSTEMI8 (27.6)13 (48.1)
 STEMI19 (65.5)12 (44.4)
 Revascularisation, No. (%)
 Medical management3 (10.3)4 (14.8)χ² (1, n=56)=6.53, p=0.038*
 PCI26 (89.7)18 (66.7)
 CABG5 (18.5)
Discharged medication information
On at least 1 ACS medication prior to admission, No. (%)13 (44.8)10 (37.0)χ² (1, n=56)=0.35, p=0.554
 Aspirin, No. (%)29 (100.0)27 (100.0)N/A
 Ticagrelor, No. (%)24 (82.8)16 (59.3)χ² (1, n=56)=3.78, p=0.052
 Clopidogrel, No. (%)5 (17.2)11 (40.7)χ² (1, n=56)=3.78, p=0.052
 DAPT, No. (%)29 (100.0)27 (100.0)N/A
 Statin, No. (%)29 (100.0)26 (96.3)χ² (1, n=56)=1.09, p=0.296
 β-blocker, No. (%)28 (96.6)26 (96.3)χ² (1, n=56)=0.03, p=0.959
 ACE inhibitor, No. (%)25 (69.0)20 (74.1)χ² (1, n=56)=1.30, p=0.253
 ARB, No. (%)2 (6.9)3 (11.1)χ² (1, n=56)=0.31, p=0.580
 GTN, No. (%)29 (100.0)21 (77.8)χ² (1, n=56)=7.22, p=0.007*
 Number of new ACS medications prescribed, Mdn (IQR)6.0 (2.0)5.0 (2.0)(U=358.5, p=0.563)
 Discharged on full ACS medication regimen, No. (%)26 (89.7)18 (66.7)χ² (1, n=56)=4.39, p=0.036*
  • *, p < 0.05; ACS, acute coronary syndrome; AMI, acute myocardial infarction; ARB, angiotensin II receptor blocker; CABG, coronary artery bypass graft; DAPT, dual antiplatelet therapy; GTN, glyceryl trinitrate; NSTEMI, non-ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction; UA, unstable angina.